Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesArray BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
Array BioPharma, 11/03/09
Array reported revenue of $7.9 million for the first quarter of fiscal 2010, compared to revenue of $5.7 million for the same period in fiscal 2009. Array invested $19.2 million in proprietary research and development during the quarter to advance its seven wholly–owned drugs in clinical development and select discovery programs. This compares to $24.5 million invested in research and development during the first quarter of fiscal 2009. Array reported a net loss of $24.8 million, or ($0.52) per share, for the first quarter, compared to a net loss of $33.7 million, or ($0.71) per share, for the first quarter in fiscal 2009.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
CEL-SCI Corporation Reports First Quarter 2010 Financial Results
CEL-SCI, 03/19/10
CEL-SCI Corporation Announces 2009 Financial Results
CEL-SCI, 03/19/10
Covidien Announces Results from 2010 Annual General Meeting
Covidien, 03/17/10
Article Search
Sponsor